Qnasl and Lacrimation increased - a phase IV clinical study of FDA data

Summary:

Lacrimation increased is reported as a side effect among people who take Qnasl (beclomethasone dipropionate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vitamin D, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Lacrimation increased when taking Qnasl. It is created by eHealthMe based on reports of 1,935 people who have side effects when taking Qnasl from the FDA, and is updated regularly.

What is Qnasl?

Qnasl has active ingredients of beclomethasone dipropionate. It is often used in allergies. eHealthMe is studying from 1,984 Qnasl users. Check the latest studies of Qnasl.

What is Lacrimation increased?

Lacrimation increased is found to be associated with 1,345 drugs and 1,796 conditions by eHealthMe. Check the latest studies of Lacrimation increased.

On Aug, 01, 2026

1,935 people reported to have side effects when taking Qnasl.
Among them, 12 people (0.62%) have Lacrimation increased.

Could Qnasl cause Lacrimation increased?

Among these 12 people:

How long have people been on Qnasl when they have Lacrimation increased? *

What is the gender of people who have Lacrimation increased when taking Qnasl? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Lacrimation increased when taking Qnasl? *

What are other drugs people take besides Qnasl? *

What are other side effects people have besides Lacrimation increased? *

Wheezing (a high-pitched whistling sound made while you breath): 3 people, 25.00%
Sneezing: 3 people, 25.00%
Insomnia (sleeplessness): 3 people, 25.00%
Muscle Spasms (muscle contraction): 3 people, 25.00%
Nasal Discomfort: 3 people, 25.00%
Productive Cough: 3 people, 25.00%
Sinus Congestion (blockage of sinus): 3 people, 25.00%
Stress And Anxiety: 3 people, 25.00%
Joint Pain: 3 people, 25.00%
Eye Pruritus (eye itching): 2 people, 16.67%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 25.00%
Pain: 3 people, 25.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 25.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
Sleep Disorder: 2 people, 16.67%
Skin Cancer: 2 people, 16.67%
Back Pain: 2 people, 16.67%
Cough: 2 people, 16.67%
Depression: 2 people, 16.67%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Qnasl and have Lacrimation increased?

- Check whether Lacrimation increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Qnasl:

Qnasl (1,984 reports)

Browse all side effects of Qnasl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lacrimation increased:

Lacrimation increased (1,345 drugs)

Browse all the conditions that are associated with Lacrimation increased:

Lacrimation increased (1,796 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on beclomethasone dipropionate (the active ingredients of Qnasl) and Qnasl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.